Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011
- PMID: 24842908
- DOI: 10.1093/cid/ciu366
Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011
Abstract
Background: In 2010, Winnipeg, Canada, experienced a doubling of invasive pneumococcal disease (IPD) rates, with a significant increase in the number of cases due to Streptococcus pneumoniae serotype 12F, which previously had accounted for very few cases each year.
Methods: All serotype 12F IPD cases reported between September 2009 and January 2011 were reviewed. Pulsed-field gel electrophoresis (PFGE) and multilocus variable number tandem repeat analysis (MLVA) were conducted on all isolates. PFGE and MLVA patterns identified several possible clusters. Additional interviews were conducted to obtain information on risk factors and outcomes.
Results: Between September 2009 and January 2011, 169 cases of IPD were identified. The number of IPD cases due to 12F serotype increased sharply from about 3-4 cases per year (6% of IPD cases) in 2007-2009 to 28 (29%) in 2010. All 12F isolates belonged to a single sequence type (ST218), and they were generally susceptible to penicillin and fluoroquinolones but not to erythromycin. Compared with cases caused by other serotypes, patients with serotype 12F were more likely to be homeless, reside in low-income inner-city communities, and engage in substance abuse, including intravenous and crack cocaine use. Subclusters identified using MLVA had even higher rates of homelessness and substance use.
Conclusions: An immunization campaign targeting high-risk groups was undertaken with pneumococcal polysaccharide vaccine, and subsequently rates of serotype 12F decreased. To our knowledge, this is the largest documented community outbreak of serotype 12F IPD and the first report of an outbreak of IPD serotype 12F in a marginalized urban population in Canada.
Keywords: homeless; invasive pneumococcal disease; outbreak; serotype 12F; surveillance.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Clonal spread of serotype 12F ST4846 Streptococcus pneumoniae.J Med Microbiol. 2019 Sep;68(9):1383-1390. doi: 10.1099/jmm.0.001047. Epub 2019 Jul 26. J Med Microbiol. 2019. PMID: 31347997
-
Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.Vaccine. 2017 Aug 16;35(35 Pt B):4587-4593. doi: 10.1016/j.vaccine.2017.07.010. Epub 2017 Jul 14. Vaccine. 2017. PMID: 28716556
-
Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.Vaccine. 2016 Jan 2;34(1):67-76. doi: 10.1016/j.vaccine.2015.11.015. Epub 2015 Nov 19. Vaccine. 2016. PMID: 26602268
-
Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD).Expert Rev Vaccines. 2019 Nov;18(11):1145-1155. doi: 10.1080/14760584.2019.1688149. Epub 2019 Nov 13. Expert Rev Vaccines. 2019. PMID: 31682762
-
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Int J Infect Dis. 2010. PMID: 19700359 Review.
Cited by
-
Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.PLoS One. 2019 Feb 21;14(2):e0212418. doi: 10.1371/journal.pone.0212418. eCollection 2019. PLoS One. 2019. PMID: 30789928 Free PMC article.
-
Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.BMC Med. 2016 Dec 21;14(1):211. doi: 10.1186/s12916-016-0755-7. BMC Med. 2016. PMID: 27998266 Free PMC article.
-
Invasive Pneumococcal Disease Clusters Disproportionally Impact Persons Experiencing Homelessness, Injecting Drug Users, and the Western United States.J Infect Dis. 2022 Aug 24;226(2):332-341. doi: 10.1093/infdis/jiac058. J Infect Dis. 2022. PMID: 35172327 Free PMC article.
-
Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness-Alaska, 2011-2020.Clin Infect Dis. 2024 Jan 25;78(1):172-178. doi: 10.1093/cid/ciad597. Clin Infect Dis. 2024. PMID: 37787072 Free PMC article.
-
Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017.Emerg Infect Dis. 2020 Oct;26(10):2378-2386. doi: 10.3201/eid2610.191531. Emerg Infect Dis. 2020. PMID: 32946721 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical